Author Interviews, CDC, Clots - Coagulation, COVID -19 Coronavirus, JAMA / 05.05.2021

MedicalResearch.com Interview with: Isaac See, MD Centers for Disease Control and Prevention COVID-19 Response Team Atlanta, Georgia MedicalResearch.com: What is the background for this study? Response: On February 27, 2021 the U.S. Food and Drug Administration (FDA) granted emergency use authorization for the Janssen/Johnson & Johnson (J&J) COVID-19 Vaccine in people 18 years of age or older in the United States.  The Janssen/J&J COVID-19 Vaccine uses a replication-deficient (i.e., cannot cause infections) human adenovirus vector.  In mid-March, the European Medicines Agency announced that they had conducted a preliminary investigation of cases of blood clots and low counts of blood cells called platelets in patients who had recently received the Oxford/AstraZeneca COVID-19 Vaccine, which uses a replication-deficient chimpanzee adenovirus vector.  This syndrome of blood clots and low platelet counts has been called thrombosis with thrombocytopenia syndrome, or TTS.  The European investigation showed that over 70% of their cases specifically involved blood clots in particular veins inside the brain, a condition caused cerebral venous sinus thrombosis (CVST), in addition to low platelet counts (thrombocytopenia is the medical term for low platelet counts). CVST is already a rare condition, and CVST with thrombocytopenia is even rarer.  By April 12, 2021, approximately 7 million doses of the Janssen/J&J COVID-19 Vaccine had been given in the United States, and six cases of CVST and thrombocytopenia after receipt of the Janssen/J&J COVID-19 Vaccine had been reported to the U.S. Vaccine Adverse Event Reporting System (VAERS), which is the U.S. national vaccine safety monitoring system.  The next day (April 13, 2021) CDC and FDA recommended a pause in use of the vaccine recommended to allow for further investigation of these events.  On April 23, 2021 data about the first 12 cases reported after authorization of the Janssen/J&J COVID-19 Vaccine were presented at an emergency meeting of the Advisory Committee on Immunization Practices (ACIP) to decide what to recommend regarding the Janssen COVID-19 vaccine.  The ACIP concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged 18 years or older outweighed the risks and reaffirmed its interim recommendation under the FDA’s Emergency Use Authorization.  The FDA’s Emergency Use Authorization includes a new warning for rare clotting events among women aged 18 to 49 years. Our report provides clinical details about these first reported 12 U.S. cases of CVST and thrombocytopenia following receipt of the Janssen COVID-19 Vaccine. (more…)
Author Interviews, Brigham & Women's - Harvard, Cancer Research, Colon Cancer, Radiation Therapy / 04.05.2021

MedicalResearch.com Interview with: James Donald Byrne, Ph.D., M.D. Department of Radiation Oncology Massachusetts General Hospital Boston, Massachusetts MedicalResearch.com: What is the background for this study? Response: Radiation therapy is used as a treatment for more than half of all cancer patients and can be highly effective at shrinking tumors and killing cancer cells. But radiation treatment can also damage healthy tissue, including tissue in the mouth and gastrointestinal tract. This tissue injury can lead to oral mucositis, esophagitis, and proctitis — painful and sometimes debilitating tissue damage. It’s estimated that these injuries occur in over 200,000 patients in the U.S. each year. Our goal was to develop personalized shields that blocked radiation from affecting healthy GI tissue. (more…)
Author Interviews, COVID -19 Coronavirus, Technology / 04.05.2021

MedicalResearch.com Interview with: Ramani “Ram” Peruvemba, MD, FASA Co-founder and CMO of HSR.health MedicalResearch.com: Would you tell us about your background?  Response: I am a dual-board certified Anesthesiologist and Pain Management physician, currently serving as the co-founder and CMO of HSR.health. I am a Health IT expert and well-versed in the clinical, regulatory, and policy issues surrounding healthcare. I leverage my expertise, professional networks, and insights to HSR.health to bring health risk information to industry. As a clinician, I formerly served as Vice Chairman of the board for the largest anesthesia provider in Maryland and led them through a private equity transaction that helped elevate our group onto a national platform. I have also served on the advisory boards of QSSI corp, a Health IT firm involved in the construction of Healthcare.gov and ultimately sold to Optum, as well as Welldoc, a digital health leader that developed the only FDA approved digital health solution for the management of diabetes. Through my role on the Maryland Health Services Cost Review Commissions Advisory Council, I play a key role in the development and implementation of the unique value based hospital payment system, the Total Cost of Care Model, in conjunction with CMS and CMMI. I currently serve on the board of the Maryland State Medical Society, MedChi, as chairman of the medical policy council, and am the President of the Maryland Society of Anesthesiologists. Most recently, I’m proud to share that I was named a 2021 Top 100 Healthcare Innovator for my leadership in HSR.health's efforts supporting COVID-19 pandemic response globally. (more…)
Author Interviews, Cancer Research, Gastrointestinal Disease, Genetic Research / 03.05.2021

MedicalResearch.com Interview with: Judy H. Cho, MD, Dean of Translational Genetics Director of The Charles Bronfman Institute for Personalized Medicine Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? Would you briefly describe Crohn's disease? Whom does it primarily affect? Response: Crohn’s disease is a chronic inflammatory intestinal disease, which affects ~3 million Americans a year. Its most typical age of onset ranges from 15-30 years, and many of those diagnosed also exhibit frequent abnormal healing and complications that constrict the digestive tract. The highest risk genetic mutations that increase risk for Crohn’s disease are found in the gene NOD2; these were first reported 20 years ago. Biological mechanisms by which NOD2 mutations drive Crohn’s disease, and especially fibrotic complications, have been incompletely described up until this point. Further, the reasons why many patients fail to respond to the commonly administered anti-TNF treatments also remain incompletely understood. (more…)
Author Interviews, Environmental Risks, Toxin Research / 01.05.2021

MedicalResearch.com Interview with: Hong-Sheng Wang PhD Department of Pharmacology and Systems Physiology University of Cincinnati College of Medicine, Cincinnati MedicalResearch.com: What is the background for this study? What is the significance of tritan? Response: Bisphenol A (BPA) is used widely in the manufacturing of consumer plastic goods. Researchers and the general public increasingly recognize the potentially harmful effect of BPA. These days BPA-based polycarbonate plastic water bottles have all but disappeared in most US stores, replaced by various BPA-free bottles including Tritan bottles. Tritan is a plastic that is not based on BPA or BPA analogues. In earlier studies, we unexpectedly found transient release of BPA from some Tritan bottles. Similar results have been reported in a past study. We wanted to figure out why the BPA release from Tritan bottles, and how consumers can best clean their bottles. (more…)
AHA Journals, Author Interviews, Baylor College of Medicine Houston, Blood Pressure - Hypertension, Microbiome / 30.04.2021

MedicalResearch.com Interview with: David J. Durgan, PhD Department of Anesthesiology Baylor College of Medicine Houston, TX  MedicalResearch.com: What is the background for this study? Response: Our lab and others had previously shown that gut dysbiosis is not only associated with hypertension, but actually plays a causal role. For example we have shown in both a genetic model of hypertension as well as an obstructive sleep apnea induced model of hypertension, that transplantation of their dysbiotic microbiota into normotensive recipients induced elevations in blood pressure. With this understanding our focus shifted to two new questions 1) How can we manipulate the microbiota to improve/prevent hypertension, and 2) What are the signals originating from the microbiota that have the capability to influence host blood pressure? These questions lead to the experimental design of this study. (more…)
Author Interviews, Cancer Research, Nutrition / 30.04.2021

MedicalResearch.com Interview with: Sa Kan Yoo MD PhD Division of Developmental Biology and Regenerative Medicine Kobe University, Kobe, Japan MedicalResearch.com: What is the background for this study? Response: Cancer is often considered as a disease of “overgrowth”. But, many known “cancer genes” in fact induce cell death rather than cell growth. Because of this phenomenon, it requires involvement of many genes, not a single “cancer gene”, for cells to become cancer. Although this protective phenomenon that cancer genes induce cell death has been known, its exact mechanism has remained unclear. We tackled this problem using the fruit fly, found its mechanism and discovered a way to manipulate it by dietary nutrition. (more…)
Author Interviews, Gender Differences, JAMA, Surgical Research / 28.04.2021

MedicalResearch.com Interview with: Anthony Almazan MD Candidate Harvard Medical School MedicalResearch.com: What is the background for this study? Response: Gender-affirming surgeries are procedures offered to alleviate psychological distress and affirm the gender identities of transgender and gender diverse (TGD) people. Requests for these surgeries have been increasing in the United States over the past decade. However, the mental health benefits of these procedures have remained controversial due to the limited evidence base on this subject. (more…)
Author Interviews, Dermatology, JAMA, Technology / 28.04.2021

MedicalResearch.com Interview with: Yun Liu, PhD Google Health Palo Alto, California MedicalResearch.com: What is the background for this study? Would you describe the system?  Does it use dermatoscopic images? Response: Dermatologic conditions are extremely common and a leading cause of morbidity worldwide. Due to limited access to dermatologists, patients often first seek help from non-specialists. However, non-specialists have been reported to have lower diagnostic accuracies compared to dermatologists, which may impact the quality of care. In this study, we built upon prior work published in Nature Medicine, where we developed a computer algorithm (a deep learning system, DLS) to interpret de-identified clinical images of skin conditions and associated medical history (such as whether the patient reported a history of psoriasis). These clinical images are taken using consumer-grade hardware such as point-and-shoot cameras and tablets, which we felt was a more accessible and widely-available device compared to dermatoscopes. Given such images of the skin condition as input, the DLS outputs a differential diagnosis, which is a rank-ordered list of potential matching skin conditions. In this paper, we worked with user experience researchers to create an artificial intelligence (AI) tool based on this DLS. The tool was designed to provide clinicians with additional information per skin condition prediction, such as textual descriptions, similar-appearing conditions, and the typical clinical workup for the condition. We then conducted a randomized study where 40 clinicians (20 primary care physicians, 20 nurse practitioners) reviewed over 1,000 cases -- with half the cases with the AI-based assistive tool, and half the cases without. For each case, the reference diagnosis was based on a panel of 3 dermatologists.  (more…)
Author Interviews, Dermatology, NEJM / 28.04.2021

MedicalResearch.com Interview with: Prof. Kristian Reich, MD, PhD Professor for Translational Research in Inflammatory Skin Diseases Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg-Eppendorf MedicalResearch.com: What is the background for this study? What are the main findings? Response: Complete skin clearance is an important treatment goal for patients with psoriasis and is closely associated with treatment satisfaction and improved quality of life. However, it remains an unmet need for many patients. The interleukin (IL)-17 isoforms IL-17A and IL-17F play central roles in psoriasis pathophysiology and are overexpressed in psoriatic tissues. Existing biologic therapies, such as secukinumab, inhibit IL-17A only. However, increasing evidence indicates that IL-17F contributes independently to the pathobiology of plaque psoriasis, and that blocking both IL-17A and IL-17F may lead to more complete suppression of inflammation and superior clinical outcomes, compared with blocking IL‑17A alone. Bimekizumab is a humanized monoclonal IgG1 antibody that has been designed to selectively inhibit IL-17F in addition to IL-17A. (more…)
Author Interviews, Cancer Research, Gender Differences, HPV, JAMA, Vaccine Studies / 27.04.2021

MedicalResearch.com Interview with: Michelle M. Chen, MD/MHS Clinical Lecturer Department of Otolaryngology-Head and Neck Surgery University of Michigan MedicalResearch.com: What is the background for this study? Response: HPV is the most common sexually transmitted infection in the United States and associated with several malignancies including oropharyngeal, cervical, vaginal, vulvar, penile, and anal cancers. In 2020, the FDA expanded the indications for HPV vaccination to include the prevention of oropharyngeal cancer, which is the most common HPV-associated malignancy and about 80% of oropharyngeal cancer patients are male. HPV vaccination rates are closely tracked for adolescents but less is known about vaccination rates for young adults. The goal of our study was to understand HPV vaccinations for young adult men and women, ages 18-21.  (more…)
Author Interviews, Circadian Rhythm, Heart Disease, Occupational Health, Sleep Disorders / 27.04.2021

Circadian misalignment is associated with a high cardiovascular risk among shift workers: MedicalResearch.com Interview with: Sara Gamboa Madeira Medical Doctor - General & Family Physician PhD Student - EnviHealth&Co - Faculty of Medicine Lisbon University MedicalResearch.com: What is the background for this study? Response: One in every five employees work in shifts across Europe1. Shift work have been associated with an increased risk for several cardiovascular diseases2 and three main mechanism have been proposed: unhealthy behaviours, disturbed sleep, and circadian misalignment. This study focused on the role of circadian misalignment, which we assessed via social jetlag. Social jetlag is calculated using the Munich Chronotype Questionnaire3 by the difference between sleep behaviour on free-days (mainly driven by the individual “biological clock”, also called chronotype) and sleep behaviour on workdays (mainly drive by the “social clock”, namely work schedules). Chronotype is an individual feature which ranges from early/morning people to late/evening people (from proverbial lark to owls), with the majority of the population falling in between as a Gaussian distribution. Therefore higher levels of social jetlag mean a greater mismatch between what your biological clock need (e.g. go to sleep at 9pm) and what your social obligations impose on you (e.g. work until midnight). (more…)
AACR, Author Interviews, Cancer Research, Genetic Research, NIH / 23.04.2021

MedicalResearch.com Interview with: Nishanth Ulhas Nair, Ph.D. Affiliation: Staff Scientist at Cancer Data Science Laboratory, Center for Cancer Research National Cancer Institute (NCI), National Institutes of Health (NIH) Bethesda, Maryland, USA. Date: April 22, 2021 Dr. Raffit Hassan and Dr. Eytan Ruppin at the National Cancer Institute (NCI) are the senior authors of this study.  MedicalResearch.com: What is the background for this study? Response: Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. An in-depth knowledge of genetic, transcriptomic and immunogenic events involved in mesothelioma is critical for successful development of prognostics and therapeutic modalities. In this study we aim to address this by exploring a new large scale patient tumor dataset of 122 mesothelioma patients, called NCI mesothelioma patient data, along with their genomic, transcriptomic, and phenotypic information. Unlike previous large-scale studies which have been focused on malignant pleural mesothelioma patients, our dataset contains an approximately equal representation of malignant pleural and peritoneal mesothelioma patients which allows to identify any differences between them. (more…)
Author Interviews, COVID -19 Coronavirus, JAMA, OBGYNE, Pediatrics / 23.04.2021

MedicalResearch.com Interview with: Aris Papageorghiou MBChB, MRCOG Professor of Fetal Medicine and the Clinical Research Director Oxford Maternal and Perinatal Health Institute University of Oxford MedicalResearch.com: What is the background for this study? Response: Our study was really guided by a key question: does Covid-19 in pregnancy increase the risk of adverse maternal and neonatal outcomes as compared with pregnant women who do not have the infection? The question is highly relevant because of the known deleterious effects of other coronavirus infections in pregnancy, e.g. SARS (severe acute respiratory syndrome) and MERS-CoV (Middle East respiratory syndrome coronavirus). In order to answer this question we undertook this multinational cohort study. (more…)
Author Interviews, COVID -19 Coronavirus, Environmental Risks / 23.04.2021

MedicalResearch.com Interview with: Margaret J. Hosie BVM&S, MRCVS, BSc. PhD. Professor of Comparative Virology MRC-University of Glasgow Centre for Virus Research United Kingdom  MedicalResearch.com: What is the background for this study? Response: SARS-CoV-2 is a new coronavirus of animal origin that recently jumped to humans and has spread rapidly across the world. It is likely that SARS-CoV-2 will establish as an endemic virus of humans, which has the potential to be transmitted to animals that live in close proximity to humans. There have been sporadic reports of infections in pet cats in households with COVID-19 patients, which demonstrates that cats are susceptible to SARS-CoV-2 infection and could act as virus reservoirs. (more…)
Author Interviews, COVID -19 Coronavirus, JNCI, Johns Hopkins, Respiratory, Vaccine Studies / 22.04.2021

MedicalResearch.com Interview with: Joel N. Blankson, MD, PhD Department of Infectious Diseases Associate Professor Cellular and Molecular Medicine Program Johns Hopkins MedicalResearch.com: What is the background for this study? Which vaccines did you evaluate? Response: Prior studies from several groups including our own have found T cell cross-recognition of peptides from SARS-CoV-2 and the common cold coronaviruses. We asked whether as a result of this cross-reactivity, immunization with the SARS-CoV-2 vaccine would also enhance T cell responses to the common cold coronaviruses. Prior studies also suggested that antibodies elicited from the mRNA vaccines had a reduced ability to neutralize the emerging variants of concern. Most of the study participants had received the Pfizer vaccine, but a few had received the Moderna vaccine.  (more…)
Author Interviews, JAMA, USPSTF, Vitamin D / 22.04.2021

MedicalResearch.com Interview with: Dr. Michael Silverstein M.D., M.P.H Professor of Pediatrics Director of the Division of General Academic Pediatrics Vice Chair of Research, Department of Pediatrics Boston University School of Medicine   MedicalResearch.com: What is the background for this study? What are the main findings? Response: Vitamin D is an important nutrient for keeping bones healthy, and it may also have a role in other aspects of good health. However, we do not have enough evidence to understand what levels of vitamin D people need to keep them healthy or what levels are too low. As a result, the Task Force determined there is not enough evidence to recommend for or against screening for vitamin D deficiency in adults who do not have signs or symptoms. It is our hope that with more research, we will be able to make a strong, evidence-based recommendation on screening for vitamin D deficiency in the future. (more…)
Author Interviews, COVID -19 Coronavirus, Environmental Risks / 22.04.2021

MedicalResearch.com Interview with: Masoud Jahandar Lashaki, Ph.D. Assistant Professor Department of Civil, Environmental and Geomatics Engineering Florida Atlantic University MedicalResearch.com: What is the background for this study? Response: Toilet flushing can generate large quantities of microbe-containing aerosols depending on the design and water pressure or flushing energy of the toilet. Based on previous reports, a variety of different pathogens which are found in stagnant water or in waste products (e.g., urine, feces, and vomit) can get dispersed widely via such aerosolization, including the legionella bacterium responsible for causing Legionnaire’s disease, the Ebola virus, the norovirus which causes severe gastroenteritis (food poisoning), and the Middle East Respiratory Syndrome coronavirus (MERS-CoV). Based on previous reports, such airborne dispersion is suspected to have played a key role in the outbreak of viral gastroenteritis aboard a cruise ship, where infection was twice as prevalent among passengers who used shared toilets compared to those who had private bathrooms. Similarly, transmission of norovirus via aerosolized droplets was linked to the occurrence of vomiting or diarrhea within an aircraft restroom, as passengers and crew who got infected subsequently were more likely to have visited restrooms than those that were not infected. The participants in the study reported that all of the restroom surfaces appeared to be clean, which indicates that infection is likely to have occurred via bioaerosols suspended within the restroom. Although many of these studies blamed flush-generated aerosols for disease outbreak, a limited number of them quantified the presence of such aerosols. Consequently, we decided to conduct this study to demonstrate the spike in aerosol concentrations following flushing.  (more…)
Author Interviews, Gender Differences, Heart Disease, JAMA / 22.04.2021

MedicalResearch.com Interview with: First Author Michelle Lee, MD, PharmD Fellow-in-training, Health Services Research & Development Michael E. DeBakey VA Medical Center, Houston, TX   Senior & Corresponding Author Salim S. Virani, MD, PhD, FACC, FAHA, FASPC Professor, Section of Cardiovascular Research Director, Cardiology Fellowship Training Program Baylor College of Medicine Staff Cardiologist, Michael E. DeBakey Veterans Affairs Medical Center Co-Director, VA Advanced Fellowship in Health Services Research & Development Michael E. DeBakey VA Medical Center, Houston, TX Investigator, Health Policy, Quality and Informatics Program Michael E. DeBakey Veterans Affairs Medical Center HSR&D Center of Innovation Houston, TX MedicalResearch.com: What is the background for this study? Response: Atherosclerotic cardiovascular disease (ASCVD), defined as ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD), or peripheral arterial disease (PAD), is the leading cause of death globally. Particularly in young ASCVD patients, secondary prevention with antiplatelet therapy and statins are extremely important in reducing disease burden. (more…)
Author Interviews, Breast Cancer, Brigham & Women's - Harvard, NEJM / 22.04.2021

MedicalResearch.com Interview with: Aditya Bardia MD, MPH Director, Breast Cancer Research Program, Attending Physician, Massachusetts General Hospital Harvard Medical School  MedicalResearch.com: What is the background for this study? Response: Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer associated with guarded prognosis. For patients with pre-treated metastatic TNBC, standard chemotherapy is associated with low response rate (5-10%) and poor progression-free survival (2-3 months), highlighting need for better therapies. Sacituzumab govitecan is an antibody drug conjugate (ADC) which  combines SN-38, an active metabolite of irinotecan, with an antibody against Trop-2, an antigen overexpressed in majority of triple negative breast cancer. (more…)
Author Interviews, Nature, Nutrition, Orthopedics, Pediatrics / 20.04.2021

MedicalResearch.com Interview with: Efrat Monsonego Ornan, Ph.D  Head of School of Nutritional Sciences Institute of Biochemistry and Nutrition The Robert H. Smith Faculty of Agriculture, Food and Environment The Hebrew University of Jerusalem MedicalResearch.com: What is the background for this study? Response: Food supplies in recent decades have been dominated by heavily processed, ready-to-eat products. Essentially, 75% of all world food sales are of processed foods. Over the past 30 years, children’s ultra-processed food intake has increased markedly, with 50% of the children in the US consuming these foods. Only in the US does UPF comprise 58% of energy intake, of which 90% is derived from added sugars. This reflects children’s excessive consumption of food and drink that are high in fat and refined sugars but do not provide appropriate levels of the proteins, vitamins and minerals required for growth. The negative health outcomes of excessive consumption of Ultra-processed food are well known, include obesity, metabolic syndrome and diabetes, and considered as the current world epidemic; the fact that children, during their postnatal development period (birth to adolescent), are the target of the Ultra-processed food industry is very disturbing in terms of public health. Bone development and growth are the characteristic phenomena of the childhood period. Yet, in spite of the huge importance of nutrition to bone development, the impact of Ultra-processed food consumption on skeleton development during childhood has never been studied directly, and this was the purpose of our study. To this end, we used young rats which are an excellent pre-clinical model for growth and fed them with either the recommended diet for their age or  a diet comprised of a typical Ultra-processed meal (a roll, hamburger, tomatoes, lettuce, ketchup and French fries) and a caloric soft drink.   (more…)
Author Interviews, Duke, Electronic Records, Health Care Systems, JAMA / 20.04.2021

MedicalResearch.com Interview with: Eugenia McPeek Hinz MD MS FAMIA Associate CMIO - DHTS Duke University Health System MedicalResearch.com: What is the background for this study? Response: Clinician burnout rates have hovered around 50% for much of the past decade.  Burnout is a significant concern in healthcare for its effects on care givers and associated downstream adverse implications on patient care for quality and safety. The ubiquitous presence of Electronic Health Records (EHR) along with the increased clerical components and after hours use has been a significant concern for contributing to provider burnout.  (more…)
Author Interviews, Psychological Science / 19.04.2021

MedicalResearch.com Interview with: Daniel J. Kruger Ph.D. Research Investigator, Population Studies Center University of Michigan  MedicalResearch.com: What is the background for this study? Response: Thorstein Veblen coined the terms “conspicuous consumption” and “conspicuous leisure” to describe the wasteful habits of the upper classes in amassing and displaying expensive goods that did not have inherent practical benefits and devoting time to pursuits such as sports and fine arts. The purpose of these socially conspicuous displays and behaviors was to advertise one’s membership in the upper, leisure class, as only the very wealthy could afford them. Veblen was inspired in part by Charles Darwin’s theory of biological evolution. Darwin himself was greatly puzzled by what he considered wasteful investments of energy in elaborate physiological displays. He saw these features as the greatest threat to his theory of natural selection. Why would something like the peacock’s tail feathers evolve, as they actually threatened survival because of their impediment to foraging and avoiding predators? Darwin was so troubled by this dilemma that the sight of a peacock’s tail feather would make him feel sick. Darwin later realized that these features provided a reproductive advantage, leading to his theory of sexual selection, including the processes of inter-sexual selection and intra-sexual competition.  (more…)
Author Interviews, COVID -19 Coronavirus, Education, Pediatrics / 16.04.2021

MedicalResearch.com Interview with: Jared Bullard MD FRCPC Associate Professor, Departments of Pediatrics & Child Health and Medical Microbiology & Infectious Diseases Max Rady College of Medicine Rady Faculty of Health Sciences Cadham Provincial Laboratory Children’s Hospital Research Institute of Manitoba MedicalResearch.com: What is the background for this study? Response: Children are well known to transmit epidemic/endemic respiratory viruses like influenza. Initial public health policy was based on that children were likely to transmit SARS-CoV-2 effectively within a community and subsequently in-person school and extracurricular activities were suspended. Initial research did not show a clear association with children driving transmission. The purpose of our study was to take respiratory samples from both children and adults with COVID-19 (all had SARS-CoV-2 detected by RT-PCR) and compare those samples by their ability to grow in cell culture and amount of virus in samples. We took 175 samples from children (97 younger than 10 years of age and 78 between 11-17 years) and compared them to 130 adult samples from the same communities in Manitoba experiencing outbreaks of COVID-19.  (more…)
Author Interviews, COVID -19 Coronavirus, JAMA / 16.04.2021

MedicalResearch.com Interview with: Emily Sickbert-Bennett PhD, MS, CIC, FSHEA Director, Infection Prevention, UNC Hospitals Administrative Director, Carolina Antimicrobial Stewardship Program, UNC Hospitals Associate Professor of Medicine-Infectious Diseases, UNC School of Medicine Associate Professor of Epidemiology, UNC Gillings School of Global Public Health MedicalResearch.com: What is the background for this study? Response: Recently public health officials have recommended doubling masks, although the initial study conducted by CDC investigators  was limited in type and combinations of masks tested, so our study compared fitted filtration efficiency of commonly available masks worn, singly, doubled or in combination. MedicalResearch.com: What are the main findings? Response:  Doubling of masks can improve the fitted filtration efficiency of masks, that is how well masks protect you from inhalation of aerosols from others.  (more…)
Alzheimer's - Dementia, Author Interviews, Cognitive Issues, Obstructive Sleep Apnea, Pulmonary Disease, University of Michigan / 16.04.2021

MedicalResearch.com Interview with: Galit Levi Dunietz  MPH, PhD Assistant Professor

Tiffany Braley, MD, MS Associate Professor

University of Michigan, Medical School Department of Neurology Department of Nutritional Sciences Ann Arbor, MI 48109-5845 MedicalResearch.com: What is the background for this study? Response: Dementia is a public health crisis that affects more than 6 million Americans.  As no treatments to effectively reverse dementia are currently available, interest has shifted toward modifiable risk factors for dementia, which may offer a critical window for prevention or intervention. Recent research suggests that obstructive sleep apnea (OSA) is a common, yet undiagnosed, risk factor for cognition impairment in older adults. However, few studies have examined whether treatment of OSA with positive airway pressure (PAP) therapy could protect those with OSA against developing dementia, says principal investigator, Dr. Tiffany Braley, MD, MS, Associate Professor of Neurology from the University of Michigan. To address this gap, Dr. Braley and Dr. Galit Levi Dunietz, PhD, MPH, Assistant Professor and sleep epidemiologist, examined associations between PAP therapy use and 3-year incidence of Alzheimer’s disease, mild cognitive impairment (MCI), or other forms of dementia (DNOS, “dementia not otherwise specified”). (more…)
Author Interviews, Psychological Science / 15.04.2021

MedicalResearch.com Interview with: Michael J. Poulin, PhD, PhD Associate Professor of Psychology College of Arts and Sciences University of Buffalo  MedicalResearch.com: What is the background for this study? Response: A great deal of research suggests that practicing mindfulness--full attention to and acceptance of one's experiences--can be good for individuals. Mindfulness seems to reduce stress and has other psychological benefits. But what about its effects on others? Does mindfulness make people more generous and helpful, or does it make them more selfish? (more…)
Author Interviews, Heart Disease, Red Meat / 15.04.2021

MedicalResearch.com Interview with: Dr Zahra Raisi-Estabragh, PhD fellow Cardiologist Trainee at Queen Mary University of London and Barts Health NHS Trust MedicalResearch.com: What is the background for this study? Response: Previous studies have linked greater consumption of red and processed meat to poorer clinical cardiovascular outcomes, for example, higher risk of having a heart attack or of dying from heart disease. However, the biological mechanisms underlying these relationships are not well understood. Furthermore, the impact of meat intake on more direct measures of heart health, such as, structure and function of the heart and blood vessels, has not been previously studied in large cohorts. Examining how meat intake may influence different aspects of cardiovascular health can help us better understand its health effects.  (more…)